The Collaboration for Increasing Influenza Vaccination in Children (CIIVIC): a meeting report

Abstract

Table 1: Interventions identified and evaluated by attendees for improving influenza vaccination in children with comorbidities.

A tailored COVID-19 vaccination pathway for children 5–11 years in Victoria, Australia

“…Apart from special risk or travel vaccines, the seasonal influenza vaccine is the only recommended but not funded vaccine that primary school children 5 to 11 years may receive. Uptake of influenza vaccine in this age group remains low (29.7% in children 5 to <10 years compared to 45.2% in children 6 months to <5 years in 2020), especially for children with no medical comorbidities [3] , [4] . In addition, several local and international studies had suggested that many parents of children 5 to 11 years were reluctant to have their child vaccinated against COVID-19 [5] , [6] , [7] , [8] , [9] , [10] , [11] .…”